American Nuclear Corporation
Pharmaceutical & Health Products · Lobbying Client
C
Influence Score
41/100
Moderate Influence
$1.6M
Total Lobby Spend
4
Policy Issues
1
Lobbyists
0
Revolving Door
American Nuclear Corporation reported $1.6 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 4 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Dept of Education
Dept of Energy
Dept of Interior
National Science Foundation
Dept of State
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | Akin Gump LLP | HCR | 1 | $69K |
| 2020 Apr-Jun | Cassidy & Associates LLP | PHAMEDHCR | 1 | $114K |
| 2020 Jul-Sep | Akin Gump LLP | HCR | 1 | $103K |
| 2020 Oct-Dec | Holland & Knight LLP | PHAGOVHCR+1 | 1 | $84K |
| 2021 Jan-Mar | Akin Gump LLP | PHA | 1 | $79K |
| 2021 Apr-Jun | K&L Gates LLP | HCR | 1 | $81K |
| 2021 Jul-Sep | Squire Patton Boggs LLP | GOV | 1 | $56K |
| 2021 Oct-Dec | BGR Group LLP | PHAHCRGOV | 1 | $63K |